Alaunos Therapeutics TCRT
NASDAQ TCRT
$1.71 +0.04 (+2.40%)
At close: Nov 10, 2026 · 4:00 PM EST

Alaunos Therapeutics (TCRT) Debt Ratio (2021 - 2023)

Updated

Alaunos Therapeutics' Debt Ratio came in at 0.23 for Q1 2023, down 21.0% from 0.29 a year earlier and down 12.5% from the prior quarter.

Analysis

Alaunos Therapeutics (TCRT) Debt Ratio (2021 - 2023) Analysis & Trends

For FY2022, Alaunos Therapeutics' Debt Ratio was 0.26, up 1.5% from FY2021.

  • Going back by year, Debt Ratio was 0.25 in FY2021.
  • The Q1 2023 figure represents the lowest quarterly Debt Ratio since Q3 2021.
  • Business Quant data shows TCRT's Debt Ratio at 0.26 (Q4 2022), 0.34 (Q3 2022) and 0.33 (Q2 2022) in the three quarters before Q1 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn 0.33
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn 0.23
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn 0.55
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn 0.41
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn 0.08
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn 0.28
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn 0.56
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn 0.51
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn 0.31
10 Alaunos Therapeutics 4.38 Mn 576,050.88 - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2023 0.23
Dec 31, 2022 0.26
Sep 30, 2022 0.34
Jun 30, 2022 0.33
Mar 31, 2022 0.29
Dec 31, 2021 0.25
Sep 30, 2021 0.21
API Access

Alaunos Therapeutics Debt Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=debt-ratio&ticker=TCRT&period=max&api_key=YOUR_API_KEY